Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
Agache, Ioana, Beltran, Jessica, Akdis, Cezmi, Akdis, Mubeccel, CaneloâAybar, Carlos, Canonica, Walter, Casale, Thomas, Chivato, Tomas, Corren, Jonathan, Del Giacco, Stefano, Eiwegger, Thomas, FirinJournal:
Allergy
DOI:
10.1111/all.14221
Date:
February, 2020
File:
PDF, 17.75 MB
2020